Marketwatch Buy Cipla, target price Rs 685: Elara Capital Admin April 27, 2020 Cipla’s recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
